Company intelligence / Profile preview

BioDelivery Sciences International

Raleigh, North Carolina, United States
Ownership
Public · BDSI
Development stage
Other
01

Overview

BioDelivery Sciences International was a commercial-stage specialty pharmaceutical company focused on pain management and addiction medicine, leveraging proprietary drug delivery technologies for rapid transmucosal delivery. Its marketed products addressed significant unmet needs in chronic pain and opioid dependence. The company was acquired by Collegium Pharmaceutical in 2022 for approximately $604 million.

Therapeutic areas
PsychiatryGastroenterologyNeurologyOncology
Modalities
Small moleculePolymer-drug conjugate (film-based)Topical gel
Industry
Biotech
02

Partnerships

Endo Pharmaceuticals (commercialization of BELBUCA in the U.S.)Arcion Therapeutics (licensed topical clonidine gel for diabetic neuropathy)Meda Pharmaceuticals (commercialization of ONSOLIS in various regions)KUNWHA Pharmaceutical (commercialization in South Korea)TTY Biopharm (commercialization in Taiwan)

Beyond the preview

Go deeper on BioDelivery Sciences International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDelivery Sciences International.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call